MyBioSource - Coronavirus (COVID-19, SARS-CoV-2, 2019-nCOV) Test Kits and Related Products
MyBioSource offers a comprehensive portfolio of SARS-CoV-2/COVID-19 coronavirus and related products. Strategies for studying COVID-19 (SARS-CoV-2) are multifaceted and new products are being developed at unprecedented speeds, our website is updated daily as new products become available.
SARS-CoV-2 has varying degrees of homology with other coronaviruses. For example, The SARS-CoV-2 (COVID-19) and SARS-CoV (SARS 2003 outbreak) coronaviruses are extremely similar. Their viral nucleocapsid phosphoproteins (NP), also known as nucleoproteins, share an identity of 94% and similarity of 97% in their amino acid sequences. High percentages of identity and homology can indicate coronavirus research products developed prior to the discovery of SARS-CoV-2 can be just as relevant as SARS-CoV-2 labeled products depending on the research study. Researchers can expand their options for studying COVID-19 by searching key word "coronavirus" on our website or by following this link and using the 'Filter By' tool.
Collectively, COVID-19 and coronavirus products can categorized into broad areas. For example, IgM/IgG ELISA Kits and Lateral Flow/Immunchromatography Products can be used to detect antibodies against COVID-19. The detection of COVID-19 antibodies can be an indication that the immune system has produced antibodies against the SARS-CoV-2 viral pathogen. PCR Reagents are designed to detect the SARS-CoV-2 virus itself as compared to IgM/IgG ELISA Kits which detect antibodies against the virus. One strategy is to use combinations of reagents such as PCR Kits to detect the virus and IgM/IgG assays to track immune responses.
Coronavirus particles, including SARS-CoV-2 viral particles contain four main structural proteins: Envelope (E), Membrane (M), Nucleocapsid (N) and Spike (S). Many researchers are also interested in COVID 19 antibodies and COVID 19 Recombinant Proteins against these structural proteins to build their own lateral flow or ELISA assays. Researchers may order proteins produced in various hosts such as E. coli, yeast, mammalian, baculovirus expression systems or even cell-free systems to match the requirements of their projects.
COVID-19 alpha B117 UK Variant Spike Antibody
COVID-19 antibodies recognizing variants of concern (VOCs)
Raw materials to build your own COVID-19 (SARS-CoV-2) IgM + IgG Combined Antibody Rapid Test Kit
Featured COVID-19 PCR Kit MBS158001!
COVID-19 Inhibitor Screening Kit: Screen for Spike (RBD)/ACE2-binding inhibitors
Measure COVID-19 blocking antibodies with SARS-CoV-2 Spike/ACE2 receptor ligand binding assay
COVID-19 serum derived positive controls/calibrators for serological assays: Convalescent COVID-19 pooled serum from donors with positive COVID-19 PCR and serology tests, available purified as an IgG fraction or as RBD Spike 1 affinity purified.
Capture COVID-19 antibodies from plasma and serum via immobilized recombinant RBD Spike 1 protein resin
COVID-19/SARS-CoV-2 Antigen Detection in saliva samples: Lateral flow/Rapid Test antibody pair combinations.
COVID-19/SARS-CoV-2 Antigen and Antibody IgG/IgM Rapid Test uncut sheets (Colloidal Gold).
Unique COVID-19 Spike S1 RBD-Nucleocapsid Protein Chimera (MBS515751) captures both Spike (MBS515753) and Nucleocapsid (MBS515752) antibodies
COVID-19 Pseudovirus + ACE2 Cell Line Testing Systems. Select COVID 19 Spike or Spike 614G Pseudovirus Particles, both are compatible with the ACE2 Stable Cell Line. Please inquire for promotional pricing.
Coronavirus OC43 (#MBS596192), HKU1 (#MBS596191), and NL63 (#MBS596194) nucleocapsid recombinant proteins may be useful for checking cross-reactivity when developing COVID-19/SARS-CoV-2 nucleocapsid assays.
View our list of available 2019 Novel Coronavirus; Coronavirus; CoV; COVID-19 virus; HCoV-2; Human Coronavirus 2019; SARS2; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; recombinant proteins, ELISA Kits for your research: